A recent study found that breast cancer–specific survival in patients with invasive lobular carcinoma was inferior compared to patients with invasive ductal carcinoma. A recent study found that breast ...

A multi-center analysis of patients with invasive lobular carcinoma, or ILC - the second most common histological subtype of invasive breast cancer in the U.S. - showed that, despite its prevalence, ...

Final analysis of the NEOMET trial of neoadjuvant metformin: Examining effects on Ki67, gene expression, and pathway analysis in primary operable breast cancer. A randomized controlled trial of ...

Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times faster than those of all other breast cancers combined over the past ...

Invasive lobular carcinoma accounts for about 10% of breast cancer diagnoses. Its incidence is increasing at the rate of 2.8% annually -- more than triple that of other breast cancers combined. This ...

Herein we report the case of an elderly gentleman diagnosed with the pleomorphic variant of invasive lobular carcinoma along with involvement of the ipsilateral axillary lymph nodes. Only three cases ...

A less common breast cancer subtype, Invasive Lobular Carcinoma (ILC), is on the rise in the US, posing detection challenges. Unlike traditional lumps, ILC often presents as subtle thickening or shape ...

Lobular breast cancer rates increased 2.8 percent per year over the past decade, compared with a 0.8 percent annual increase for all other breast cancers. Lobular breast cancer grows in a linear ...

BERLIN — New data from the SOFT and TEXT trials showed that women with premenopausal invasive lobular carcinoma, than those with invasive ductal carcinoma, experience a greater magnitude of benefit ...